OEM Trademarks On Reprocessed Devices Do Not Mislead Hospitals - AMDR
This article was originally published in The Gray Sheet
Executive Summary
FDA should not require the removal of OEM trademarks and names from reprocessed devices because it would be inconsistent with the Kansas District Court's finding in U.S. Surgical Corp. v. Orris, Inc., according to the Association of Medical Device Reprocessors.